pharma news, views and analysis - pharmaphorum.com

Trending

in News
Gilead launches phase 3 trials of coronavirus antiviral remdesivir
February 27, 2020 Share
X
Gilead launches phase 3 trials of coronavirus antiviral remdesivir
https://pharmaphorum.com/news/gilead-launches-phase-3-trials-of-coronavirus-antiviral-remdesivir/
in News
Takeda buys US biotech PvP Biologics for $330 million
February 27, 2020 Share
X
Takeda buys US biotech PvP Biologics for $330 million
https://pharmaphorum.com/news/takeda-buys-us-biotech-pvp-biologics-for-330-million/

Latest News

US trials of Gilead’s remdesivir begin against COVID-19 coronavirus

US trials of Gilead’s remdesivir begin against COVID-19 coronavirus

The first US trial of Gilead’s unapproved antiviral remdesivir has officially begun against the novel coronavirus disease COVID-19.

X

US trials of Gilead’s remdesivir begin against COVID-19 coronavirus

https://pharmaphorum.com/news/us-trials-of-gileads-remdesivir-begin-against-covid-19-coronavirus/

Gilead surges after WHO says remdesivir may combat coronavirus

Gilead surges after WHO says remdesivir may combat coronavirus

Gilead’s share price has surged after health experts said its antiviral drug remdesivir is showing signs of efficacy

X

Gilead surges after WHO says remdesivir may combat coronavirus

https://pharmaphorum.com/news/gilead-surges-after-who-says-remdesivir-may-combat-coronavirus/

GSK teams up with Clover on coronavirus vaccine

GSK teams up with Clover on coronavirus vaccine

GlaxoSmithKline has agreed to supply its vaccine adjuvant technology to Clover Biopharma, to help the Chinese biotech in

X

GSK teams up with Clover on coronavirus vaccine

https://pharmaphorum.com/news/gsk-teams-up-with-clover-on-coronavirus-vaccine/

Views & Analysis

Deep Dive: R&D Disruption

Deep Dive: R&D Disruption

With costs skyrocketing and return on investment plummeting, R&D arguably needs disruption more than any other area of

X

Deep Dive: R&D Disruption

https://pharmaphorum.com/r-d/views-analysis-r-d/deep-dive-rd-disruption/

Listen and support: How to conduct a patient-centric clinical study

Listen and support: How to conduct a patient-centric clinical study

Clinical trial sponsors understand the value of patient-centric studies, but success relies on a time-consuming paradigm shift and

X

Listen and support: How to conduct a patient-centric clinical study

https://pharmaphorum.com/r-d/views-analysis-r-d/listen-and-support-how-to-conduct-a-patient-centric-clinical-study/

Millendo’s Julia Owens on leadership in rare diseases

Millendo’s Julia Owens on leadership in rare diseases

Rare disease specialists Millendo Therapeutics are hoping their drug livoletide will become the first treatment for Prader-Willi syndrome.

X

Millendo’s Julia Owens on leadership in rare diseases

https://pharmaphorum.com/r-d/views-analysis-r-d/millendo-julia-owens-leadership-rare-diseases/

Debates & Insights

Navigating new frontiers: Ways to find space in the future RA market

Navigating new frontiers: Ways to find space in the future RA market

Overview Rheumatoid arthritis (RA) has been a major growth driver for the pharmaceutical industry over the last 15

X

Navigating new frontiers: Ways to find space in the future RA market

https://pharmaphorum.com/r-d/navigating-new-frontiers-ways-to-find-space-in-the-future-ra-market/

Understanding blockchain – a practical guide for life sciences companies

Understanding blockchain – a practical guide for life sciences companies

Within the life science industry, uptake of blockchain is in the early stages, but with investment levels in

X

Understanding blockchain – a practical guide for life sciences companies

https://pharmaphorum.com/digital/insights-digital/understanding-blockchain-life-sciences/

Marketing science – brand innovation for pharma

Combining fields such as economics, statistics and operations research, marketing science has for some time operated under-the-radar as

X

Marketing science – brand innovation for pharma

https://pharmaphorum.com/debates-insight-sales-marketing/marketing-science-brand-innovation-for-pharma/

Partner Content

J+D Forecasting launches innovative pharmaceutical sales forecasting software

J+D Forecasting launches innovative pharmaceutical sales forecasting software

Sales+ is the first Excel add-in that provides all the

X

J+D Forecasting launches innovative pharmaceutical sales forecasting software

https://pharmaphorum.com/partner-content/jd-forecasting-launches-innovative-pharmaceutical-sales-forecasting-software/

HPAPI 2020 Conference – Programme Announced

HPAPI 2020 Conference – Programme Announced

HPAPI Industry Insights

X

HPAPI 2020 Conference – Programme Announced

https://pharmaphorum.com/partner-content/hpapi-2020-conference-programme-announced/

13th Annual Pharma Resource Planning and Portfolio Management

13th Annual Pharma Resource Planning and Portfolio Management

Prioritizing Projects with Tools, Data, and Governance

X

13th Annual Pharma Resource Planning and Portfolio Management

https://pharmaphorum.com/events/13th-annual-pharma-resource-planning-and-portfolio-management/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com